We have developed a method to generate genetically engineered Jurkat T cells armed with a CAR comprising the anti-HER2 VHH as targeting moiety. From an immune camel library, five VHH clones were selected as a set of oligoclonal anti-HER2 VHHs that exhibited diverse binding abilities and joined them to CD28-CD3味 and CD28-OX40-CD3味 signaling endodomains. Jurkat T cells expression of VHH-CARs and cell functions were evaluated.
The oligoclonal engineered T cells showed higher proliferation, cytokine secretion and cytotoxicity than each individual VHH-CAR-engineered Jurkat T cells.
The combination of superior targeting ability of oligoclonal VHHs with the third generation CAR can substantially improve the function of engineered T cells.
Antigen-specific directed oligoclonal T cells are alternatively promising, but safer systems, to combat tumor cells.